NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/05/2024
Voltar para busca
Dado oficial do USPTO
CITAGENIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
14/05/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 41
Data de depósito
30/01/2019
Data de registro
14/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/05/2024
Última transação
14/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
5
Tipo de titular
03
Localização do titular
Quebec, CA
Examinador
BULLOFF, TOBY ELLEN
Unidade examinadora
N10
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the word "CITAGENIX" with a stylized "N".
Titulares e representantes
Titulares
Citagenix Inc.
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 35Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Distributorship services and wholesale ordering services of membranes for medical usebone graft material for bone graftingdentalorthopedic and veterinary applications; distributorship services and wholesale ordering services of medical devices destined to professionals in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics; online retail store services featuring membranes for medical usebone graft material for bone graftingdentalorthopedic and veterinary applications; online retail store services featuring medical devices destined to professionals in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics; developing marketing strategies for others of bone regeneration products for professionals in the field of bone graftingdentistryveterinary science and orthopedics; developing marketing strategies for others of medical devices destined to professionals in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics
Classe 41
Providing educational servicesclassesseminarsworkshops and training services in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics; arranging and conducting classesseminars and workshops in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
14/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
PUBO
PUBLISHED FOR OPPOSITION
27/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/01/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
25/10/2023
GNSL
LETTER OF SUSPENSION E-MAILED
25/10/2023
CNSL
SUSPENSION LETTER WRITTEN
25/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/10/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
24/10/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/08/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/08/2023
CNSI
SUSPENSION INQUIRY WRITTEN
03/08/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
31/01/2023
GNSL
LETTER OF SUSPENSION E-MAILED
31/01/2023
CNSL
SUSPENSION LETTER WRITTEN
31/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2023
ALIE
ASSIGNED TO LIE
30/01/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
23/01/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/08/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/08/2022
CNSI
SUSPENSION INQUIRY WRITTEN
01/08/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/02/2022
GNSL
LETTER OF SUSPENSION E-MAILED
01/02/2022
CNSL
SUSPENSION LETTER WRITTEN
01/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/02/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
25/01/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/08/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/08/2021
CNSI
SUSPENSION INQUIRY WRITTEN
02/08/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
22/07/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
23/09/2020
GNSL
LETTER OF SUSPENSION E-MAILED
23/09/2020
CNSL
SUSPENSION LETTER WRITTEN
23/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/09/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
17/09/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/04/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/04/2020
CNSI
SUSPENSION INQUIRY WRITTEN
06/04/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/04/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/10/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/10/2019
CNSL
SUSPENSION LETTER WRITTEN
01/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/09/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/04/2019
GNRT
NON-FINAL ACTION E-MAILED
11/04/2019
CNRT
NON-FINAL ACTION WRITTEN
11/04/2019
DOCK
ASSIGNED TO EXAMINER
11/04/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
16/03/2019
ALIE
ASSIGNED TO LIE
16/03/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/02/2019
NWAP
NEW APPLICATION ENTERED
02/02/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CITAGENIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.